Phe-Met-Arg-Phe amide trifluoroacetate

目录号: PL09401 纯度: ≥98.0%
Phe-Met-Arg-Phe amide trifluoroacetate 是一种神经肽,在肽能神经元中激活 K+ 电流,ED50 为 23 nM,这种作用具有剂量依赖性。
CAS No. :159237-99-7
商品编号 规格 价格 会员价 是否有货 数量
PL09401-5mg 5mg ¥793.00 请登录
PL09401-10mg 10mg ¥1265.00 请登录
PL09401-25mg 25mg ¥2605.00 请登录
PL09401-50mg 50mg ¥3905.00 请登录
PL09401-100mg 100mg ¥5865.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Phe-Met-Arg-Phe amide trifluoroacetate
英文名称
Phe-Met-Arg-Phe amide trifluoroacetate
英文别名
Phe-Met-Arg-Phe amide trifluoroacetate;Phe-Met-Arg-Phe amide (trifluoroacetate)
Cas No.
159237-99-7
分子式
C33H44F6N8O8S
分子量
826.81
包装储存
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
详情描述
Phe-Met-Arg-Phe amide trifluoroacetate 是一种神经肽,在肽能神经元中激活 K+ 电流,ED50 为 23 nM,这种作用具有剂量依赖性。
产品详情
Phe-Met-Arg-Phe amide trifluoroacetate 是一种神经肽,在肽能神经元中激活 K+ 电流,ED50 为 23 nM,这种作用具有剂量依赖性。
生物活性
Phe-Met-Arg-Phe amide trifluoroacetate is an activator of K current, with ED 50 of 23 nM in the peptidergic caudodorsal neurons.
性状
Solid
IC50 & Target[1][2]
ED50: 23 nM (K current)
体外研究(In Vitro)
In the molluscan central nervous system, Phe-Met-Arg-Phe amide (FMRFa) acts on K channels in sensory, motor-, and neuroendocrine neurones. Phe-Met-Arg-Phe amide activates a novel K current that is characterized by a combined voltage- and receptor-dependent gating mechanism, with both factors being necessary for opening of the channels. Phe-Met-Arg-Phe amide (1 μM) significantly inhibits glucose stimulated (300 mg/dL) insulin release (p<0.005) and somatostatin release (p<0.01) from the isolated perfused pancreas. Phe-Met-Arg-Phe amide (FMRF-NH2) (1 and 10 μM) is without effect on glucagon secretion, either in low glucose (50 mg/dL), high glucose (300 mg/dL), or during arginine stimulation (5 mM). has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Phe-Met-Arg-Phe amide (FMRFamide) stimulates growth hormone secretion in conscious OVX rats. The presence of Phe-Met-Arg-Phe amide-like immunoreactivity in neuronal elements in the hypothalamus suggested a role for this in the hypothalamic control of the anterior pituitary function. The injection of 200 ng (313.8 picomoles) of FMRFamide (in 2 uL) produces a significantly increased plasma GH 15 min after injection. The GH-increasing effect of 400-800 ng (627-1255 picomoles) of FMRFamide is already developed after 5 min and lasted up to 30 min. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
SequenceShortening
FMRF-NH2
Sequence
Phe-Met-Arg-Phe-NH2
参考文献
[1]. Kits KS, et al. Phe-Met-Arg-Phe-amide activates a novel voltage-dependent K+ current through a lipoxygenasepathway in molluscan neurones. J Gen Physiol. 1997 Nov;110(5):611-28.
[2]. Sorenson RL, et al. Phe-met-arg-phe-amide (FMRF-NH2) inhibits insulin and somatostatin secretion and anti-FMRF-NH2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. 1984 Jul-Aug;5(4):777-82.
溶解度数据
In Vitro: DMSO : 100 mg/mL (120.95 mM; Need ultrasonic)H2O : 20 mg/mL (24.19 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Kits KS, et al. Phe-Met-Arg-Phe-amide activates a novel voltage-dependent K+ current through a lipoxygenasepathway in molluscan neurones. J Gen Physiol. 1997 Nov;110(5):611-28.
[2]. Sorenson RL, et al. Phe-met-arg-phe-amide (FMRF-NH2) inhibits insulin and somatostatin secretion and anti-FMRF-NH2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. 1984 Jul-Aug;5(4):777-82.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2